ELIDEL CANCERS & PROTOPIC CANCERS, LYMPHOMAS & FDA WARNINGS
The Food and Drug Administration (FDA) has advised health care professionals that Elidel (pimecrolimus) and Protopic (tacrolimus) have failed to work and that because of a potential cancer risk associated with their use that a black box warning is forthcoming. The two eczema creams Elidel and Protopic, must carry a strong warning of cancer risk. The Food and Drug Administration said Thursday.research shows the creams are absorbed into the body and can cause skin cancer and lymphoma. The creams will carry a “black box” warning, which is the strongest warning carried on drugs and medicines.
Talk to a Lawyer at www.Elidel-Cancer.com about a ELIDEL CANCER LAWSUIT
ECZEMA DRUGS POSSIBLY LINKED TO CANCER & LYMPHOMA
The Food and Drug Administration (FDA) has advised health care professionals that Elidel (pimecrolimus) and Protopic (tacrolimus) have failed to work and that because of a potential cancer risk associated with their use that a black box warning is forthcoming. The two eczema creams Elidel and Protopic, must carry a strong warning of cancer risk. The Food and Drug Administration said Thursday.research shows the creams are absorbed into the body and can cause skin cancer and lymphoma. The creams will carry a “black box” warning, which is the strongest warning carried on drugs and medicines. Further the FDA stated that babies should not be treated with the creams at all, the FDA said.“The data showed that the risk of cancer increased as the amount of the drug given increased. The FDA said in a statement the data also included a small number of reports of cancers in children and adults treated with Elidel or Protopic.
ELIDEL & PROTOPIC NOT APPROVED TO TREAT INFANTS
In February 2005, a FDA advisory panel said they were concerned the companies were aggressively advertising the medicines to treat infants and others with skin problems the creams which these creams were not approved to treat.Elidel, known generically as pimecrominum, and Protopic known generically as tacrolimus, should be used only as directed and only after other eczema treatments have failed to work because of the risk, the FDA said.
ELIDEL & PROTOPIC LINKED TO SKIN CANCER & LYMPHOMA
Since the FDA approved Protopic in 2000 and Elidel in 2001, seven cases of lymphoma and six skin cancer cases have been reported in patients, the FDA said.Animal tests have suggested the creams could cause cancer, the FDA added.“The manufacturers of the products have agreed to conduct research to determine whether there is an actual risk of cancer in humans, and, if so, its extent,” the FDA said.“Both products are applied to the skin to control eczema by suppressing the immune system. FDA’s Public Health Advisory specifically advises physicians to weigh the risks and benefits of these drugs in adults and children,” the agency added.
ELIDEL WARNING & PROTOPIC WARNINGS TO USERS
If you or a loved one have used Elidel or Protopic and you have been diagnosed with Cancer, Lymphoma, Tumors or other Immune System Disorders, then call us immediately to discuss what can be done to protect your legal rights. FREE CONFIDENTIAL CONSULTATION at 1-800-883-9858 or 1-800-468-4878 (Toll Free)
The Willis Firm is currently investigating potential legal actions on behalf of a number of Elidel & Protopic users and their families. Additionally Mr. Willis is talking to leading oncologists and immunologists in order to assembly a medical and legal team to investigate and pursue possible products liability claims and lawsuits against the makers and distributors of these two drugs.
Mr. Willis is a Board Certified Personal Injury Trial Lawyer, certified by the Texas Board of Legal Specialization. For a Free Evaluation of your Elidel Lawsuit or Protopic Lawsuit Claim, please complete the following form and we will contact you promptly. This information will not be shared with anyone outside the Willis Law Firm and will remain confidential at all times. Talk with a Board Certified Personal Injury Trial Lawyer about your legal rights of a against the drug industry and others.
Call Us Toll Free at 1-800-883-9858 or 1-800-468-4878 or E-mail us your questions on Free Case Evaluation Form.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment